Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DermTech, Inc. - Common Stock (NQ: DMTK )

0.0940 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jun 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about DermTech, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
DermTech Announces Release Date for Second-Quarter 2022 Financial Results
From DermTech, Inc.
Via Business Wire
DermTech Appoints Two New Board Members
From DermTech, Inc.
Via Business Wire
DermTech Joins PeDRA Corporate Council, Supporting Efforts to Address Pediatric Skin Diseases
From DermTech, Inc.
Via Business Wire
DermTech to Present on Genomic Innovation in Dermatology at AHIP 2022
From DermTech, Inc.
Via Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
DermTech to Present at the William Blair Growth Stock Conference
From DermTech, Inc.
Via Business Wire
DermTech Sponsors The Sun Bus to Bring Free Skin Cancer Screenings to More Than 50 Locations Across the U.S.
From DermTech, Inc.
Via Business Wire
DermTech Presents New Research Differentiating Atopic Dermatitis and Psoriasis at the Society for Investigative Dermatology’s Annual Meeting
From DermTech, Inc.
Via Business Wire
DermTech Reinforces Longstanding Mission to Help Reduce Melanoma Deaths, Aligning with the Biden Administration’s Renewed ‘Cancer Moonshot’ Program
From DermTech, Inc.
Via Business Wire
DermTech Kicks Off Second Annual #Stickit2Melanoma Campaign, Raising Awareness for Melanoma and the Importance of Skin Exams
From DermTech
Via Business Wire
DermTech Reports First-Quarter 2022 Financial Results; Company Affirms Full-Year 2022 Outlook
From DermTech, Inc.
Via Business Wire
DermTech Announces Publication of New GvHD Clinical Research Conducted in Collaboration with Memorial Sloan Kettering Cancer Center
From DermTech, Inc.
Via Business Wire
DermTech Expands Telehealth Application, DermTech Connect, Across 44 States
From DermTech, Inc.
Via Business Wire
DermTech to Showcase DermTech Stratum, an Expanded Translational Medicine Service Offering, at San Diego’s Inaugural ‘Innovation Day’ Event
From DermTech, Inc.
Via Business Wire
DermTech Announces Release Date for First-Quarter 2022 Financial Results
From DermTech, Inc.
Via Business Wire
DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From DermTech, Inc.
Via Business Wire
DermTech Management to Present at Upcoming Investor Conferences
From DermTech, Inc.
Via Business Wire
DermTech Welcomes Adelle Walker as Vice President of Consumer Products
From DermTech, Inc.
Via Business Wire
DermTech to Announce Fourth Quarter and Full-Year Financial Results
From DermTech, Inc.
Via Business Wire
DermTech Management to Participate in Upcoming Investor Conferences
From DermTech, Inc.
Via Business Wire
DermTech Unveils DermTech Stratum, an Expanded Translational Medicine Service Offering for Non-invasive Biomarker Analysis
From DermTech, Inc.
Via Business Wire
DermTech Presents Precision Approaches to Personalized Dermatology at 2021 Dermatology Drug Development Summit
From DermTech, Inc.
Via Business Wire
DermTech Reports Third Quarter 2021 Financial Results
From DermTech, Inc.
Via Business Wire
DermTech and DermatologistOnCall Enter Agreement to Improve Access to the DermTech Melanoma Test with Noninvasive, At-Home Sample Collection
From DermTech, Inc.
Via Business Wire
DermTech Management to Participate in Upcoming Investor Conferences
From DermTech, Inc.
Via Business Wire
DermTech to Announce Third Quarter Financial Results on November 9, 2021
From DermTech, Inc.
Via Business Wire
DermTech Presents in Expert Panel at Inaugural Alliance for Innovation in Integrated Healthcare Summit
From DermTech
Via Business Wire
DermTech Announces New Appointment of L’Oréal USA Leader Nathalie Gerschtein Keraudy to its Board of Directors
From DermTech, Inc.
Via Business Wire
DermTech Sponsors San Diego Open; Partners with Tennis Pro Brandon Nakashima to Raise Awareness for Sun Safety
From DermTech, Inc.
Via Business Wire
DermTech Study, “Non-Invasive Detection of Genomic Atypia Increases Real-World NPV and PPV of the Melanoma Diagnostic Pathway and Reduces Biopsy Burden,” Published in SKIN: The Journal Of Cutaneous Medicine
From DermTech, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.